Direct Therapeutics Report issue

For profit Phase 2
Founded: Redwood City CA United States (1991)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
1995
NCT00038441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

carmustine (bicnu) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 2)

Central Nervous System Neoplasms (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Neoplasms (Phase 2)

Nervous System Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1